1. DSpace at MEDIU
  2. مقالات مستوردة من دليل الدوريات مفتوحة المصدر DOAJ
  3. Health Sciences
Please use this identifier to cite or link to this item: http://dspace.mediu.edu.my:8181/xmlui/handle/123456789/4572
Full metadata record
DC FieldValueLanguage
dc.creatorPérez-Calvo J-
dc.creatorGiraldo P-
dc.creatorPastores G-
dc.creatorFernández-Galán M-
dc.creatorMartín-Nuñez G-
dc.creatorPocoví M-
dc.date2003-
dc.date.accessioned2013-05-30T11:24:14Z-
dc.date.available2013-05-30T11:24:14Z-
dc.date.issued2013-05-30-
dc.identifierhttp://www.jpgmonline.com/article.asp?issn=0022-3859;year=2003;volume=49;issue=2;spage=127;epage=31;aulast=Pérez-Calvo-
dc.identifierhttp://www.doaj.org/doaj?func=openurl&genre=article&issn=00223859&date=2003&volume=49&issue=2&spage=127-
dc.identifier.urihttp://koha.mediu.edu.my:8181/jspui/handle/123456789/4572-
dc.descriptionBACKGROUND: Enzyme replacement therapy (ERT) for Gaucher′s disease with alglucerase or imiglucerase is efficacious, well-tolerated and safe. However, cost considerations, visits to medical facilities, potentially duration of theray for life, are issues of major concern to a proportion of treated patients and has, in some cases, led to the withdrawal of therapy. AIMS: To elucidate whether an extension of the interval between enzyme infusions to once every three weeks is as effective in maintaining the clinical responses achieved with the bi-monthly regimen. MATERIALS AND METHODS: Four patients with an optimal response to ERT (at 30 units/kg every two weeks for an average of 27 months), were subjected to enzyme dose/frequency changes that essentially constituted a reduction in cumulative dose over the treatment period. Patients were assessed every 6 months for alterations in haematological parameters, plasma chitotriosidase levels, liver and spleen size, and bone symptoms. RESULTS: All patients had to resume the previous infusion schedule of once every two weeks; one because of new bone marrow infiltrates, two because of visceral enlargement, and the fourth due to progressive anaemia. CONCLUSIONS: This limited experience suggests that a reduction in enzyme dose associated with an extended interval between infusions may lead to variable disease control, and underscores the need for individualization of enzyme therapy.-
dc.publisherMedknow Publications-
dc.sourceJournal of Postgraduate Medicine-
dc.titleExtended interval between enzyme therapy infusions for adult patients with Gaucher′s disease type 1.-
Appears in Collections:Health Sciences

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.